Robert Booth

SmartBead Technologies Ltd. used to provide drug development and research services. It used to develop medical diagnostic products based on multiplexing technology and ultraplex, which enables bar coding at a molecular level. The company was founded in 2000 and was headquartered in Cambridge, UK.

Pronostics Ltd. operates as a clinical diagnostics company. It offers diagnostic and disease monitoring applications. The company’s products include UltraPlex line of automated multiplexing solutions, such as UltraPlex multiplexed assays to multiplex a range of assays for applications in direct immunoassay; and UltraPlex ANA, a barcoded immunoassay for testing of autoimmune disease biomarkers that allows hospitals and laboratories to perform automated profiles of patient. The company was founded in 2000 and is headquartered in Cambridge, the United Kingdom.

Part of Dassault Systèmes SA, Synomics Ltd. implements software primarily for the biological and pharmaceutical industry. The company is based in Cambridge, UK. Peter Juul Kristensen has been the CEO of the British company since 2020. Synomics was acquired by BIOVIA, Inc., part of Dassault Systèmes SA from April 30, 2014 on June 29, 2001 for $3.50 million.

Endeavors Plc operated as holding company. The company through its subsidiaries engaged in the design, development, and sale of software products and services in the United States and the United Kingdom. It offered application software streaming technology for consumer, games-ondemand, and enterprise delivery and management of applications over the Internet and private networks. Endeavors was headquartered in London, the United Kingdom.

General Electric Canada Co. manufactures and markets products for the generation and distribution of electricity. It offers aircraft engines, power generation, water processing, and security technology to medical imaging, business & consumer financing, and media content. The company was founded by Thomas Edison in 1892 and is headquartered in Mississauga, Canada.

Biotica Technology Ltd. develops and manufactures pharmaceutical products. The company focuses on the discovery and development of novel therapeutics derived from polyketide through the targeted alteration of polyketide biosynthetic pathways. The firm was founded in 1996 by Peter Leadlay and Jim Staunton and is headquartered in Saffron Walden, GB.

Isomerase Therapeutics Ltd. operates as a drug discovery and development company. It specializes in biosynthetic medicinal chemistry and synthetic biology, microbial natural products, microbial natural products, and semisynthetic chemistry. The company was founded by Barrie Wilkinson, Matthew Gregory, and Steven Moss in 2012 and is headquartered in Cambridge, the United Kingdom.